Interagency Patent Coordination and Improvement Act of 2022
Summary
Interagency Patent Coordination and Improvement Act of 2022 This bill establishes the Interagency Task Force on Patents to support coordination and communication between the U.S. Patent and Trademark Office (PTO) and the Food and Drug Administration (FDA) on activities relating to patents for human drugs and biological products. The task force's duties shall include establishing a process for the PTO to request from the FDA information relating to certain patent applications to help patent examiners carry out their duties.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jun 2022
Committee Review
Floor Vote
President
Introduced Jun 16, 2022
Last action Aug 2, 2022
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
5
Key actions
2
Committee
3
Aug 2, 2022
Upper · Passed
Committee on the Judiciary. Reported by Senator Durbin with an amendment in the nature of a substitute. Without written report.
upper
Jul 28, 2022
Upper · Passed
Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
upper
Jun 16, 2022
Committee
Read twice and referred to the Committee on the Judiciary.
upper
Jun 16, 2022
Introduced
Introduced in Senate
upper
1 primary · 5 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about S 4430
Scope: US
Hi! I can help you understand S 4430. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline